Filter
107
Filtered Results: 107
Text search:
anticoagulación
Featured
Recommendations
16
New Publications
10
Language
Document type
Guidelines
48
No document type
21
Studies & Reports
19
Manuals
7
Fact sheets
7
Training Material
3
Strategic & Response Plan
2
Countries / Regions
India
14
Latin America and the Carribbean
7
Germany
7
Brazil
5
Colombia
3
Argentina
3
South Africa
3
Mozambique
2
Africa
2
Asia
2
Western and Central Europe
2
Spain
2
Ethiopia
2
Angola
2
Nepal
1
Kenya
1
Rwanda
1
Syria
1
Nigeria
1
Malaysia
1
Philippines
1
Global
1
USA
1
Haiti
1
Guinea-Bissau
1
Venezuela
1
Tanzania
1
Western Pacific Region
1
Paraguay
1
Portugal
1
Indonesia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Guidelines
41
COVID-19
26
Drugs & Medical Equipment
8
Non-communicable Diseases
5
Cardiovascular Diseases
4
NCD
3
Women & Child Health
3
Studies & Reports
3
Surgery & Anaesthesia
3
Countries
2
Capacity Building
2
Disease Prevention & Control
2
Dental & Eye Care
1
Hepatitis
1
Snakebites
1
Primary Health Care
1
Age & Elderly
1
Reproductive Health
1
Toolboxes
Clinical Guidelines
26
Country specific documents
19
Prevention & Strategies
5
Stroke
4
Paediatrics
4
Immunization Guidelines
4
Long COVID/ Post-COVID Syndrome
4
Essential Medicines & Devices Lists
4
For Pregnant Women
3
Vaxzevria (Astra Zeneca)
3
Studies & Reports
3
Training, others
2
Essential Medicines & Medical Devices
2
Resuscitation
2
Capacity Building & Resources
2
Neurological Disorders
2
Clinical Guidelines
1
Infection Control General
1
For Health Worker
1
Scientific & Research Studies
1
Gender Aspects
1
HIV and COVID-19
1
COVID-19
1
Communication Material
1
TB/COVID-19
1
Others
1
Handbooks & Manuals
1
Others
1
Essential Medicines
1
Model Formulary
1
Pharmacy Practice
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
Intensive Care Unit
1
Patient Safety
1
Clinical Aspects & Diagnosis
1
Statistics & Facts
1
Clinical Aspects & Diagnosis
1
Co-Morbidities (except TB)
1
Assessment & Response
1
Clinical Guidelines
1
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud...
Orientations provisoires 19 juillet 2021
interim guidance, 19 July 2021 (arabic version)
Since the description of the first case of COVID-19 in Wuhan, Hubei province in China, in December 2019, much knowledge has been accumulated about the dynamics of evolution of the SARS-CoV-2 virus, contagion, disease progression, prevention and treatment.
The European Resuscitation Council Guidelines for Resuscitation provide specific instructions for how resuscitation should be practiced and take into account ease of teaching and learning, as well as the science. They were developed by Europeans and have been specifically written with European pract...
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
The pandemic has emphasized the high risk of avoidable harm to patients, health workers, and the general public, and has identified a range of safety gaps across all core components of health systems at all levels.
The rapid review ‘Implications of the COVID-19 pandemic for patient safety’ ex...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional diseases. Despite prior perception of low NCDs mortality rates, current evidence suggests t...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ...
